Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension
- IDN-6556-14 Investigators
Research output: Contribution to journal › Article › peer-review
144
Link opens in a new tab
Scopus
citations